Vicagrel
- Generic Name
- Vicagrel
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18ClNO4S
- CAS Number
- 1314081-53-2
- Unique Ingredient Identifier
- 8A63K3TN0U
- Background
Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel).
- Indication
预防和治疗因血小板聚集状态引起的心、脑及其他动脉的循环障碍疾病。
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 1000
- Registration Number
- NCT06577519
- Locations
- 🇨🇳
General Hospital of Northern Theater Command of Chinese PLA, Shenyang, Liaoning, China
A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 24
- Registration Number
- NCT04919551
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath